Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
2003

Survivin Expression in Pediatric Brain Tumors

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): Altura R A, Olshefski R S, Jiang Y, Boué D R

Primary Institution: Columbus Children's Research Institute, The Ohio State University

Hypothesis

Survivin plays a functional role in normal ependymal growth and/or neural stem cell differentiation.

Conclusion

The study found that nuclear Survivin expression correlates inversely with tumor grade in pediatric ependymomas and choroid plexus tumors.

Supporting Evidence

  • Survivin was strongly expressed in normal ependymal and choroid plexus cells.
  • Lower nuclear Survivin levels were associated with higher tumor grades.
  • All grade I choroid plexus tumors showed high nuclear positivity for Survivin.

Takeaway

The study looked at a protein called Survivin in brain tumors of children and found that lower levels of this protein in the nucleus might mean the tumor is more aggressive.

Methodology

The study used immunohistochemistry to evaluate Survivin expression in tumor and nonmalignant brain tissues from pediatric patients.

Limitations

The study's sample size was not large enough to assess the impact of nuclear Survivin staining as an independent prognostic factor.

Participant Demographics

Patients included children diagnosed with ependymomas and choroid plexus tumors, ages ranging from 3 to 20 years.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601334

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication